Zobrazeno 1 - 6
of 6
pro vyhledávání: '"João M. Frazão"'
Autor:
Luciano Pereira, André Weigert, Maria Teresa Mendes, Manuel Augusto Gonçalves Amoedo, Catarina Meng, Marco Marques, João M. Frazão
Publikováno v:
Nefrología. 43:197-203
There is scarce clinical experience with etelcalcetide in patients with secondary hyperparathyroidism uncontrolled with cinacalcet. The effect of etelcalcetide on serum sclerostin levels remains to be clarified.Prospective cohort study in prevalent h
Autor:
Juliana Macêdo Magalhães, Luciano Pereira, João M. Frazão, Janete Quelhas-Santos, Sandra Martins, Catarina Carvalho, Ricardo Neto
Publikováno v:
Clinical Kidney Journal
Background Disordered mineral and bone metabolism is a common complication of chronic kidney disease (CKD). Bone biopsy remains the gold standard tool for evaluating renal osteodystrophy (ROD), but it is an invasive procedure. Despite a growing inter
Autor:
João M. Frazão, Ricardo Neto
Publikováno v:
Clinical Kidney Journal
Background Disordered bone and mineral metabolism are a common complication of chronic kidney disease (CKD). Phosphate binders are often prescribed in advanced CKD, when hyperphosphataemia develops. Little is known about the role of these drugs in ea
Autor:
Luciano Pereira, Ricardo Neto, João M. Frazão, Janete Quelhas-Santos, Juliana Macêdo Magalhães
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 10, p e0258284 (2021)
PLoS ONE, Vol 16, Iss 10, p e0258284 (2021)
Background Vascular calcification (VC) is a common finding in chronic kidney disease (CKD) patients and predicts subsequent cardiovascular morbidity and mortality in this population. Vascular calcification is linked to disordered mineral metabolism a
Autor:
Barton S. Levine, Keith C. Norris, Russell W. Chesney, Sergio R. Acchiardo, John D. Bower, Laura L. Douglass, Loganathan Elangovan, Jerald F. Sigala, Hla M. Maung, John A. Robertson, Darlene M. Kyllo, William G. Goodman, João M. Frazão, Mark P. Rutkowski, Bobby J. Kelley, Charles W. Bishop, Jack W. Coburn, Hector J. Rodriguez, Richard B. Mazess
Publikováno v:
American Journal of Kidney Diseases. 37:532-543
Most reports on the effectiveness and side effects of oral versus parenteral calcitriol or alfacalcidol in hemodialysis patients with secondary hyperparathyroidism show no advantage of parenteral treatment. The efficacy and safety of intravenous doxe
Publikováno v:
Nephrology Dialysis Transplantation. 13:68-72
Calcitriol and alfacalcidol are useful in suppressing parathyroid hormone (PTH ) in haemodialysis patients, but hypercalcaemia and hyperphosphataemia are frequent. The vitamin D analogue, la-hydroxyvitamin D 2 (1αD 2 ), has a higher therapeutic inde